Fluence Energy's Houston Ramp-Up Stumble Prompts UBS to Halve Its Target — and Trim 2027-28 Too
Published on 10/27/2026 at 14:12 | Editorial boerse-global.de
UBS cut its price target on Fluence Energy from $12 to $6 on Tuesday, keeping a "Neutral" rating, and the reasoning matters more than the headline number: the bank now expects the drag from US contract-manufacturing delays to outlast the current fiscal year. Its revised models also lower EBITDA estimates for fiscal 2027 and fiscal 2028, a signal that the brokerage sees a slower production ramp and margin pressure rather than a simple timing shift of revenue.
The downgrade to the target — a halving — embeds roughly $190 million in additional costs tied to delays at contract-manufacturer-operated plants in Houston. No fresh company release triggered the move; the note extends an ongoing reassessment of manufacturing and guidance risk, and it lands alongside a securities class-action complaint filed by Hagens Berman on the same day.
Guidance Already Pointed the Way
The cautious stance builds on Fluence's own revisions. The company trimmed its fiscal 2026 revenue outlook to about $2.4 billion, down from a prior midpoint of roughly $3.0 billion, citing the Houston contract-manufacturing ramp. On adjusted EBITDA, it guided to a loss of around $200 million, against an earlier midpoint of about a $10 million loss. Both figures are projections, not reported annual results.
Those numbers frame the UBS recalculation. What is at stake is not just whether Fluence can win projects but whether it can execute them without extra charges. Delayed deliveries complicate revenue recognition, and when they coincide with higher production costs the effect is twofold: shipments slip while manufacturing gets more expensive.
Should investors sell immediately? Or is it worth buying Fluence Energy?
BrunsbĂĽttel: A Firm Order, a Separate Risk
Set against that operational headwind is a concrete win. Vattenfall awarded Fluence a turnkey supply and long-term service contract for its planned battery storage facility in BrunsbĂĽttel, announced on October 14. The deal covers 254 megawatts of power and more than 1,000 megawatt-hours of storage capacity. Fluence is to supply battery storage units, power conversion systems and energy management software, and handle commissioning and long-term support.
Construction is scheduled to begin in 2027, with commissioning targeted by the end of 2028 — meaning the bulk of execution still lies ahead. For investors, order intake and execution risk deserve separate treatment: Brunsbüttel expands the project pipeline, while the UBS cost estimates concern the manufacturing ramp.
Two Kinds of Exposure
The class-action allegations run parallel to the production problems but address a different question. Hagens Berman claims Fluence failed to adequately disclose risks tied to new or underperforming contract-manufacturing sites and their effect on deliveries and revenue. These are allegations, not established facts. The distinction holds for economic analysis too: the lawsuit concerns how risks were previously communicated, whereas the UBS cuts target their expected financial consequences.
Fluence Energy at a turning point? This analysis reveals what investors need to know now.
What remains is execution in the factory. UBS sees the burden extending beyond the current fiscal year, which makes a dependable production ramp the key variable — not only for deliveries but for any hope of steadier earnings planning.
Ad
Fluence Energy Stock: New Analysis - 27 October
Fresh Fluence Energy information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
